Thioredoxin Glutathione Reductase as a Novel Drug Target: Evidence from Schistosoma japonicum

BACKGROUND: Schistosomiasis remains a major public health concern affecting billions of people around the world. Currently, praziquantel is the only drug of choice for treatment of human schistosomiasis. The emergence of drug resistance to praziquantel in schistosomes makes the development of novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, LiJun, Li, JiaHuang, Xie, ShuYing, Qian, ChunYan, Wang, Jie, Zhang, Wei, Yin, XuRen, Hua, ZiChun, Yu, ChuanXin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285170/
https://www.ncbi.nlm.nih.gov/pubmed/22384025
http://dx.doi.org/10.1371/journal.pone.0031456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285170/
https://www.ncbi.nlm.nih.gov/pubmed/22384025
http://dx.doi.org/10.1371/journal.pone.0031456

Ejemplares similares